RE:RE:RE:RE:Shelf prospectus New Yacht or not, PMN like I have stated in the past will definitely need more Capital to succeed. I bet you they have a positive outlook on approval Aducanumab being extended until futher notice which is why PMN will be needing more Capital. As RC stated, we won't see too much difference in SP if Aducanumab is approved or not. I like to invest in Companies that are in Business long term. At this point, I feel very positive about PMN. Cheers and Good Luck to all!